Orchestra BioMed Holdings (OBIO) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 71.6%
EBITDA Margin: -25295.5%
Op. Margin: -25404.5%
Net Margin: -26994.3%

Op. margin of -25404.5% is down 23092.7% YoY — costs are rising relative to revenue. Net margin at -26994.3% and gross margin of 71.6% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit